1. Home
  2. DLTH vs PEPG Comparison

DLTH vs PEPG Comparison

Compare DLTH & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$3.60

Market Cap

121.7M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.65

Market Cap

113.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTH
PEPG
Founded
1989
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.7M
113.3M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
DLTH
PEPG
Price
$3.60
$1.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$11.17
AVG Volume (30 Days)
102.1K
2.4M
Earning Date
06-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
64.12
25.61
EPS
N/A
N/A
Revenue
$565,184,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.01
52 Week High
$4.66
$7.80

Technical Indicators

Market Signals
Indicator
DLTH
PEPG
Relative Strength Index (RSI) 67.24 23.13
Support Level $3.39 $1.57
Resistance Level $4.66 $5.37
Average True Range (ATR) 0.19 0.13
MACD 0.01 0.09
Stochastic Oscillator 86.52 26.68

Price Performance

Historical Comparison
DLTH
PEPG

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: